Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population.

Title : Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population

Source : CINAHL
ID : 29693361
Authors : Wittbrodt, Eric T.; Eudicone, James M.; Bell, Kelly F.; Enhoffer, Devin M.; Latham, Keith; Green, Jennifer B
Year : 2018
Disease Category : Endocrine disease
Focused Population : Not Specified
Priori/Posteriori : Both
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : Yes
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Participants in different trials : Yes
Real-world data sources : NHANES
Target Population Data Type Levels : National